510(K) CLEARANCES 84 ▲14RECALLS POSTED 39 ▲27CLASS I 6 ▲2PMA DECISIONS 47 ▲11WEEK ENDING / FDA DATA AS OF
Medical Device
ManufacturingTHE TRADE PAPER OF THE FACTORY FLOOR
SUBSCRIBE / SIGN IN
K950916Substantially Equivalent

Cd3 Fitc/cd8 R-Pe Monoclonal Antibody Combination

Caltag Laboratories, Inc., South San Francisco CA / Traditional, Substantially Equivalent
FDA source (opens on fda.gov)

K950916 is the FDA 510(k) clearance record for CD3 FITC/CD8 R-PE MONOCLONAL ANTIBODY COMBINATION, a class II device, cleared for Caltag Laboratories, Inc. on under FDA product code GKZ (Counter, Differential Cell). FDA records list 12 510(k) clearances for Caltag Laboratories, Inc., from to . As of , FDA records show no recalls naming K950916.

Clearance record

Decision date
Received
(295 days to decision)
Product code
GKZ Counter, Differential Cell
Regulation
21 CFR 864.5220
Device class
Class II
Review panel
Hematology
Applicant
Caltag Laboratories, Inc. 436 Rozzi Pl., South San Francisco CA
510(k) summary
Statement
Third party review
No

Clearances, product code GKZ

Trailing 12 months
4 clearances under product code GKZ in the twelve months to October 2026, January 2026 the highest month at 1.
Show the numbers
Monthly 510(k) clearances under FDA product code GKZ, trailing twelve months
MonthClearances
November 20250
December 20250
January 20261
February 20261
March 20260
April 20260
May 20261
June 20260
July 20260
August 20260
September 20261
October 20260